Finally, current or recent use of postmenopausal hormones modestly increases the risk of postmenopausal breast cancer.
FORBES: After 40 Years Of Research, What Do We Know About Preventing Breast Cancer?
There is no screening test for it either, but most women are diagnosed early because of postmenopausal bleeding.
The five test men and 13 postmenopausal women, who were an average of 60 years old, all had high serum cholesterol levels.
The researchers studied 5, 212 postmenopausal women between the ages of 40 and 96.
CNN: Health - Hormone replacement may influence mammography accuracy
For example, obesity actually appears to be protective for premenopausal breast cancer, whereas it is a risk factor for postmenopausal breast cancer.
FORBES: After 40 Years Of Research, What Do We Know About Preventing Breast Cancer?
Being overweight is strongly associated with the risk of postmenopausal breast cancer.
Lilly wants to measure the viscosity of postmenopausal women, to see which face the risk of heart disease should they go on estrogen therapy.
Following menopause, the main source of estrogen is from fat deposits, and this is believed to explain the association of obesity with postmenopausal breast cancer.
FORBES: After 40 Years Of Research, What Do We Know About Preventing Breast Cancer?
In the late 1990s many doctors believed postmenopausal women could cut their risk of heart disease by more than half with daily doses of hormones.
In osteoporosis the RANK ligand protein is all too effective in producing the breakdown effect, resulting in debilitating hip fractures in postmenopausal women and others.
Novartis is conducting a big study to see whether the dug can also prevent relapse in the much bigger group of postmenopausal women with breast cancer.
On Friday the drug was approved for use in combination with Aromasin for postmenopausal women with recurring HER2-negative breast cancer, after treatment with the drugs Femara and Arimidex.
An understanding of the hormonal nature of breast cancer has led to the development of highly effective treatments for the most common form of breast cancer in postmenopausal women.
FORBES: After 40 Years Of Research, What Do We Know About Preventing Breast Cancer?
Weight gain of 25 to 35 pounds is normal in pregnancy and not associated with an increase in risk for either premenopausal or postmenopausal breast cancer, the study found.
It found that hormone therapy, often prescribed to relieve menopausal symptoms and protect against osteoporosis, in healthy postmenopausal women increased the risk of breast cancer, heart disease and stroke.
In one recent study researchers in Germany tested the effects of three hours a week of strength training, jumping and high-impact aerobics on 50 postmenopausal women at risk for osteoporosis.
Vivus, aiming at surgically menopausal women, found a 64% increase in "satisfying" sexual activity in a small trial of premenopausal women (placebo was 42%) and is now launching a larger late-stage test in postmenopausal women.
The compound may help desire and arousal disorders in postmenopausal women, perhaps by stimulating estrogen receptors at sites in the body, including the brain, says Michael Diamond, an obstetrician and gynecologist at Wayne State University.
The researchers compared a group of 105 women who had all suffered recurrent spontaneous miscarriages with a carefully matched control group of 91 postmenopausal women who had never had a miscarriage and who had given birth at least twice.
Let's look at one of the biggest changes in medical practice of the past decade: the decision to stop putting millions of postmenopausal women on hormone replacement therapy, which postulated that replacing the estrogen and progesterone their bodies were no longer making would do them long-term good.
Epidemiologic studies over the past 40 years have identified numerous risk factors for breast cancer, including: older age, an early age at menarche, a late age at first full-term birth, not having children, a family history of breast cancer in a first-degree relative, greater height, higher circulating estrogen levels, postmenopausal hormone use, breast density, history of breast biopsies, obesity (for postmenopausal breast cancer), and exposure to ionizing radiation.
FORBES: After 40 Years Of Research, What Do We Know About Preventing Breast Cancer?
应用推荐